G. Edward Griffin marshals the evidence that cancer is a deficiency disease – like scurvy or pellagra – aggravated by the lack of an essential food compound in modern man’s diet. That substance is vitamin B17. In its purified form developed for cancer therapy, it is known as Laetrile.
This story is not approved by orthodox medicine. The FDA, the AMA, and The American Cancer Society have labeled it fraud and quackery. Yet the evidence is clear that here, at last, is the final answer to the cancer riddle.
Why has orthodox medicine waged war against this non-drug approach? The author contends that the answer is to be found, not in science, but in politics – and is based upon the hidden economic and power agenda of those who dominate the medical establishment.
With billions of dollars spent each year on research, with other billions taken in on the sale of cancer-related drugs, and with fund-raising at an all-time high, there are now more people making a living from cancer than dying from it. If the solution should be found in a simple vitamin, this gigantic industry could be wiped out over night. The result is that the politics of cancer therapy is more complicated than the science.
MAINTENANCE DOSAGE IN HUMANS
Obtained from The Physician’s Handbook of Vitamin B17 Therapy
Dr. Krebs suggests that over a period of time a total dosage in excess of 300 grams is the average in controlling a moderate cancer crisis. The time needed to develop the maximum response is four months to over a year. If good response is obtained within the first three weeks, the dosage may be reduced or the clinical schedule changed to suit the convenience of the patient.
A severe cancer crisis brought under control may be maintained in a quiescent state by the oral administration of 1 gram of Vitamin B-17 daily. However some patients claim to feel “better” or “safer” with a 1.5 to 2.0 grams of 13-17 daily. Such dosage is determined by the patient’s sense of well being, gain in strength, increased appetite, weight gain, and psychological improvement with reduction of anxiety and nervousness, with exhibition of a more nearly normal degree of optimism and interest in his environment.
Abnormal situations, stress or ill health of any kind have been known to be followed by a renewed outbreak or progression of the cancer process in some patients. The attending physician should be aware of these possibilities with patients in whom the cancer is under control. When a cancer crisis has been successfully controlled for more than two years, with patient showing good objective responses in weight gain, increased strength, return to a more nearly normal state of activity and vigour, with negative CGH urine tests, and with an improvement in x-rays or other objective evidence, the maintenance dose may be reduced to dietary levels of vitamin B17 of at least 500 milligrams per day.